Try our beta test site
1 study found for:    23539696 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Evaluation of AVE5026 as Compared to Placebo for the Extended Prophylaxis of Venous Thromboembolism in Patients Having Undergone Hip Fracture Surgery
Condition: Venous Thromboembolism
Interventions: Drug: Open-label Semuloparin sodium;   Drug: Placebo (for Semuloparin sodium);   Drug: Semuloparin sodium

Study has passed its completion date and status has not been verified in more than two years.